NFAT5 and cervical cancer: The results of ChIP assay (Figure 9E) revealed that the binding of TonEBP to the proposed SLC5A3 promoter 35 was significantly upregulated in the cervical cancer tissues of four patients but was relatively low in matched adjacent non-cancerous cervical epithelial tissues (Figure 9E).